Oral Lesions Developed in Post‐Hematopoietic Stem Cell Transplant Patients and the Role of Cryogun Cryotherapy
Clinical and Experimental Dental Research · 2026-06 · 12 (3)
DOI: 10.1002/cre2.70389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dental Research, online erschienen am 15.06.2026. Verfasst von Pei Hsuan Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, National Taiwan University Hospital Yun Lin Branch, Douliu, Taiwan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cryotherapy, Precancerous Conditions, Mouth Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To investigate the development of oral premalignant and malignant lesions as a major long‐term complication following hematopoietic stem cell transplantation.
Methods
This single‐center retrospective study identified 17 patients who developed 26 pathology‐confirmed oral premalignant and malignant lesions after hematopoietic stem cell transplantation, with a latency period ranged from 5 months to nearly 18 years.
Results
Twelve high‐grade lesions developed in nine patients at a median of 9 years post‐hematopoietic stem cell transplantation, most commonly on the tongue. All high‐grade lesions were surgically treated, with complete response in most cases. One patient developed nodal disease 9.6 years after surgery, and another experienced local recurrence of moderate dysplasia 2 years post‐treatment, which was controlled by cryogun cryotherapy. Most patients had chronic graft‐versus‐host disease and histories of immunosuppressant therapy. Cryogun cryotherapy was used to treat 10 premalignant lesions across seven patients, involving the tongue, gingiva, and buccal or labial mucosa. This treatment achieved an 80% complete response rate with minimal scarring. Verrucous hyperplasia was the most common diagnosis ( n = 9).
Conclusions
Routine, long‐term oral screening is critical for patients after hematopoietic stem cell transplantation. Cryogun cryotherapy shows promise as an effective, minimally invasive option for managing early oral verrucous lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dentistry, National Taiwan University Hospital Yun Lin Branch, Douliu, Taiwan.
- Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
- School of Dentistry, Graduate Institute of Clinical Dentistry, National Taiwan University, Taipei, Taiwan.
- Faculty of Dentistry, Oral Medical and Biological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
- Basic and Translation Research, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
- School of Biomedical Engineering, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Zitieren
APA
Lu, P. H., Liu, K. Y. P., Ng, S. P., & Poh, C. F. (2026). Oral Lesions Developed in Post‐Hematopoietic Stem Cell Transplant Patients and the Role of Cryogun Cryotherapy. Clinical and Experimental Dental Research, 12(3). https://doi.org/10.1002/cre2.70389
Vancouver
Lu PH, Liu KYP, Ng SP, Poh CF. Oral Lesions Developed in Post‐Hematopoietic Stem Cell Transplant Patients and the Role of Cryogun Cryotherapy. Clinical and Experimental Dental Research. 2026;12(3). doi:10.1002/cre2.70389
BibTeX
@article{Lu2026,
author = {Lu, Pei Hsuan and Liu, Kelly Yi Ping and Ng, Samson P and Poh, Catherine F},
title = {Oral Lesions Developed in Post‐Hematopoietic Stem Cell Transplant Patients and the Role of Cryogun Cryotherapy},
journal = {Clinical and Experimental Dental Research},
year = {2026},
volume = {12},
number = {3},
doi = {10.1002/cre2.70389}
}
EUVIMED